(Amazon chief executive Jeffrey P. Bezos owns The Washington Post.) Kentucky's attorney general sued Johnson & Johnson on Wednesday, accusing the pharmaceutical maker of devising a deceptive marketing scheme that …
As a result the stock fell 17%. While the size of the fall may be an overreaction, it …
AEI23m
NOW WATCH: Wall Street's biggest bull explains why trade war fears are way overblown See Also: SEE ALSO: 'Losing …
In reaction, Canaccord Genuity double-downgraded the stock to "sell" from "buy," and slashed its price target by 80% to $2, saying the shares "could see …
But Shire isn’t making things easy: The firm has already rebuffed Takeda’s …
Biogen’s stock was still inactive. Part of the payment will include $625 million to buy about 11.5 million Ionis shares, or about 9.2% of the shares outstanding, at $54.34 a share, which is 18.5% above Thursday’s closing price of $45.85. …
A little under a year ago the penny stock of Synthetic Biologics $SYN gyrated higher on the news that its drug SYN-004 …
Kwmg Llc sold 25,618 shares as the company’s stock declined 15.28% with the market. The institutional investor held …